Friday, 29 March 2024


Servier lays foundation stone for new research institute

21 June 2019 | News

At its new Research Institute, the Servier group will work alongside other scientific organizations thus providing a natural opportunity for collaboration and potential innovation

Servier, an independent international pharmaceutical company, has laid the foundation stone of its future Research Institute in the Paris-Saclay cluster. The new Servier Paris-Saclay Research Institute will house all of the Group's research activities located in France by 2022.

Olivier Laureau, President of Servier said, “It is with great joy and pride to lay the foundation stone of the future Servier Paris-Saclay Research Institute, within this innovative and dynamic ecosystem. This milestone further exemplifies the Group’s ongoing commitment to the discovery of innovative therapeutic solutions for patients. By combining the research activities of our four French sites into a single, unique, and state-of-the-art center in Paris-Saclay, the Servier group is continuing to support France whilst attracting researchers from around the world.”

At its new Research Institute, the Servier group will work alongside other scientific organizations thus providing a natural opportunity for collaboration and potential innovation.

Furthermore, the Servier group will be able to rely on the expertise of CentraleSupélec, the French Alternative Energies and Atomic Energy Commission (CEA), the French National Center for Scientific Research, Paris-Sud University, the Ecole Normale Supérieure and the Ecole Polytechnique, some of which have already been working with the Group for several years.

“The laying of the first stone of the new Servier Research Institute is an embodiment of the collaboration between the Paris-Saclay Public Development and the Servier group. We are delighted to welcome the Servier group to our cluster, whose presence will strengthen the potential for innovation and excellence of the Paris-Saclay site. The synergies that will be created between the major players, thanks to the Servier group’s presence, will make France an even more attractive prospect in terms of scientific and medical innovation,” explained Philippe Van de Maele, Managing Director of Paris-Saclay Public Development (EPAPS).

Claude Bertrand, Executive Vice President R&D at Servier said, “This new Research Institute is a tremendous tool that will make the Servier group even more effective at addressing the unmet needs of patients. By uniting our experts at what will become the Group's largest research center, we can ensure an even faster exploration of new therapeutic pathways, whilst benefiting from the cutting-edge knowledge and experience offered by one of the most dynamic research environments available, where creativity, innovation, and entrepreneurship are both encouraged and valued.”

Jean-Michel Wilmotte, architect for the project said, “This harmonious and highly ambitious project is designed around green spaces and a central harnessing element, a symbol of the unity and dynamic nature of the Servier group. This crystalline circular structure interacts with slender sculpted spaces to promote conversation, create synergies, and drive real innovation.”

Designed by Wilmotte et Associés, the new Research Institute will be built to the highest environmental standards to promote the health and well-being of its occupants and to protect biodiversity. It aims to achieve both HQE (High Environmental Quality) and WELL certification, as well as the BiodiverCity® label. Construction of the future Servier Research Institute, covering approximately 45,000 m2 , is scheduled for completion in 2022.

 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account